Canada Issues Guidance on Abbreviated New Drug Submissions

Drug Industry Daily
A A
Health Canada released two draft guidances to clarify proposed changes to the agency’s abbreviated new drug submission (ANDS) pathway for generics.

To View This Article:

Login

Subscribe To Drug Industry Daily